Table 2

ELISA reactivity of sera from normal blood donors and cancer patients: Tests for OY-TES-1 antibody

SeraELISA, positive/total
Healthy donors0/20 (0%)
Bladder cancer3/58 (5.2%)
Prostate cancer3/85 (3.5%)
Liver cancer10/95 (10.5%)
Colon cancer6/58 (10.3%)
Lung cancer3/66 (4.5%)
Total25/362 (6.9%)